je.st
news
Home
› Galectin Therapeutics Announces Discovery Program For New Anti-Galectin Drugs In Collaboration With The University Of Georgia
Galectin Therapeutics Announces Discovery Program For New Anti-Galectin Drugs In Collaboration With The University Of Georgia
2013-02-19 10:00:00| drugdiscoveryonline News Articles
Galectin Therapeutics, the leading developer of therapeutics that target galectin proteins to treat fibrosis and cancer, announced recently the establishment of a collaborative drug discovery program with Dr. Geert-Jan Boons’ laboratory located in the Complex Carbohydrate Research Center at the University of Georgia
Tags: of
program
university
georgia
Category:Biotechnology and Pharmaceuticals